Daniel Stauder
Stock Analyst at Citizens JMP
(4.23)
# 1,489
Out of 5,090 analysts
48
Total ratings
53.5%
Success rate
20.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniel Stauder
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SYK Stryker | Reiterated: Buy | $390 | $291.86 | +33.63% | 1 | Oct 30, 2026 | |
| MBOT Microbot Medical | Initiated Coverage: Buy | $2.5 | $1.09 | +129.36% | 1 | Oct 23, 2026 | |
| IART Integra LifeSciences Holdings | Reiterated: Buy | $22 | $12.75 | +72.55% | 1 | Oct 22, 2026 | |
| ATRC AtriCure | Reiterated: Buy | $52 → $68 | $61.25 | +11.02% | 16 | Oct 21, 2026 | |
| STXS Stereotaxis | Reiterated: Buy | $4 → $3 | $0.8626 | +247.79% | 2 | Aug 27, 2026 | |
| AORT Artivion | Reiterated: Buy | $53 → $48 | $22.58 | +112.58% | 10 | May 8, 2026 | |
| LMAT LeMaitre Vascular | Reiterated: Buy | $118 → $127 | $80.94 | +56.91% | 11 | May 6, 2026 | |
| STIM Neuronetics | Reiterated: Buy | $3 → $7 | $2.25 | n/a | 6 | Mar 5, 2025 |
Stryker
Oct 30, 2026
Reiterated: Buy
Price Target: $390
Current: $291.86
Upside: +33.63%
Microbot Medical
Oct 23, 2026
Initiated Coverage: Buy
Price Target: $2.5
Current: $1.09
Upside: +129.36%
Integra LifeSciences Holdings
Oct 22, 2026
Reiterated: Buy
Price Target: $22
Current: $12.75
Upside: +72.55%
AtriCure
Oct 21, 2026
Reiterated: Buy
Price Target: $52 → $68
Current: $61.25
Upside: +11.02%
Stereotaxis
Aug 27, 2026
Reiterated: Buy
Price Target: $4 → $3
Current: $0.8626
Upside: +247.79%
Artivion
May 8, 2026
Reiterated: Buy
Price Target: $53 → $48
Current: $22.58
Upside: +112.58%
LeMaitre Vascular
May 6, 2026
Reiterated: Buy
Price Target: $118 → $127
Current: $80.94
Upside: +56.91%
Neuronetics
Mar 5, 2025
Reiterated: Buy
Price Target: $3 → $7
Current: $2.25
Upside: n/a